Pfizer and BioNTech to study enhanced Covid-19 vaccine candidate

By NS Healthcare Staff Writer

28 Jul 22

The Phase 2 trial of BNT162b5 will enrol around 200 participants, aged between 18 and 55 years, who…

PharmaceuticalsClinical trials

VistaGen’s social anxiety drug PH94B fails in Phase 3 clinical trial

By NS Healthcare Staff Writer

25 Jul 22

PH94B is designed to regulate the olfactory-amygdala neural circuits of fear and anxiety, but it did not achieve…

PharmaceuticalsClinical trials

US FDA partially halts Sanofi’s Phase 3 tolebrutinib trial in US

By NS Healthcare Staff Writer

01 Jul 22

The US FDA has paused new enrolment in the US and told the participants who have been enrolled…

PharmaceuticalsClinical trials

Roche’s potential Alzheimer’s drug crenezumab fails in Phase 2 clinical trial

By NS Healthcare Staff Writer

17 Jun 22

In the study, crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation…

PharmaceuticalsClinical trials

GSK’s RSV vaccine for older adults shows positive outcomes in Phase 3 trial

By NS Healthcare Staff Writer

13 Jun 22

The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults…

PharmaceuticalsClinical trials

US FDA halts actual use trial of Sanofi’s anti-impotence drug Cialis

By NS Healthcare Staff Writer

31 May 22

Cialis is a PDE-5 inhibitor therapy that can be used to treat erectile dysfunction (ED), the signs and…

PharmaceuticalsClinical trials

Moderna, IAVI to begin first clinical trial of mRNA HIV vaccine in Africa

By NS Healthcare Staff Writer

19 May 22

The Phase 1 clinical trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for…

PharmaceuticalsClinical trials

Roche’s anti-TIGIT drug combination fails in Phase 3 lung cancer trial

By NS Healthcare Staff Writer

12 May 22

The Phase 3 study evaluated the tiragolumab plus Tecentriq in 534 patients with first-line PD-L1-high metastatic non-small cell…

PharmaceuticalsClinical trials

Comirnaty booster dose effective in five to 11-year-olds, says study

By NS Healthcare Staff Writer

18 Apr 22

In the Phase 2/3 clinical trial in 140 children, a booster dose of Comirnaty has increased neutralizing antibodies…

PharmaceuticalsClinical trials

AstraZeneca, Ionis’ antisense drug reduces LDL-C levels by 73% in Phase 2b trial

By NS Healthcare Staff Writer

05 Apr 22

AZD8233 is a novel, investigational ASO therapy designed to reduce blood cholesterol levels in patients with hypercholesterolemia (elevated…

PharmaceuticalsClinical trials